• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 2006 年癌症发病与死亡。

Cancer incidence and mortality in china, 2006.

机构信息

National Office for Cancer Prevention and Control/National Central Cancer Registry, Cancer Institute, Chinese Academy of Medical Sciences, Beijing 100021, China.

出版信息

Chin J Cancer Res. 2011 Mar;23(1):3-9. doi: 10.1007/s11670-011-0003-9.

DOI:10.1007/s11670-011-0003-9
PMID:23467577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3587531/
Abstract

OBJECTIVE

To describe the cancer incidence and mortality rates in 2006 and evaluate the cancer burden in China.

METHODS

Cancer registration data in 2006 from 34 cancer registries were collected, evaluated and pooled to calculate cancer incidence and mortality rates. The data analyses included mortality to incidence ratio (MI), morphological verification percentage (MV%) and proportion of death certification only (DCO%). Cumulative incidence and mortality rates were calculated using crude data, age-standardized data, and specific data for cancer site, age, sex and area (urban or rural).

RESULTS

In 2006, 34 registries with qualified registration data covered a total population of 59,567,322 (46,558,108 in urban areas and 13,009,214 in rural areas). The crude and age-standardized cancer incidence rates were 273.66 per 100,000 and 190.54 per 100,000, respectively. The crude and age-standardized cancer mortality rates were 175.70 per 100,000 and 117.67 per 100,000, respectively. Cancers of lung, stomach, colon and rectum, liver, and breast in female were the five most common forms of cancer in China, which accounted for 58.99% of all new cancer cases. Lung cancer was the leading cause of cancer death, followed by stomach cancer, liver cancer, esophageal cancer and colorectal cancer.

CONCLUSION

Cancer is still an important public health issue in China with an increasing disease burden. Specifically, the incidence rates for lung cancer, colorectal cancer and breast cancer were increasing, but those for stomach cancer and esophageal cancer were decreasing. However, age-specific incidence rate remained stable, indicating that the aging population was the major source of the increasing cancer burden.

摘要

目的

描述 2006 年癌症发病率和死亡率,并评估中国的癌症负担。

方法

收集 2006 年来自 34 个癌症登记处的癌症登记数据,并进行评估和汇总,以计算癌症发病率和死亡率。数据分析包括死亡率与发病率比(MI)、形态学验证百分比(MV%)和仅死亡证明比例(DCO%)。使用粗数据、年龄标准化数据以及癌症部位、年龄、性别和地区(城市或农村)的特定数据计算累积发病率和死亡率。

结果

2006 年,34 个具有合格登记数据的登记处覆盖了总人口 59567322 人(城市地区 46558108 人,农村地区 13009214 人)。粗发病率和年龄标准化发病率分别为 273.66/100000 和 190.54/100000。粗死亡率和年龄标准化死亡率分别为 175.70/100000 和 117.67/100000。在中国,肺癌、胃癌、结肠癌和直肠癌、肝癌和乳腺癌是最常见的五种癌症,占所有新癌症病例的 58.99%。肺癌是癌症死亡的主要原因,其次是胃癌、肝癌、食管癌和结直肠癌。

结论

癌症仍然是中国一个重要的公共卫生问题,疾病负担不断增加。具体而言,肺癌、结直肠癌和乳腺癌的发病率呈上升趋势,但胃癌和食管癌的发病率呈下降趋势。然而,特定年龄组的发病率保持稳定,表明人口老龄化是癌症负担增加的主要原因。

相似文献

1
Cancer incidence and mortality in china, 2006.中国 2006 年癌症发病与死亡。
Chin J Cancer Res. 2011 Mar;23(1):3-9. doi: 10.1007/s11670-011-0003-9.
2
[Cancer statistics in China, 2016].《2016年中国癌症统计数据》
Zhonghua Zhong Liu Za Zhi. 2023 Mar 23;45(3):212-220. doi: 10.3760/cma.j.cn112152-20220922-00647.
3
Report of incidence and mortality in China cancer registries, 2009.中国癌症登记地区 2009 年肿瘤登记发病与死亡报告
Chin J Cancer Res. 2013 Feb;25(1):10-21. doi: 10.3978/j.issn.1000-9604.2012.12.04.
4
[Incidence and mortality of cancers appeared in the Hebei provincial cancer registry system in 2011].2011年河北省癌症登记系统中出现的癌症发病率和死亡率
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Aug;36(8):846-51.
5
National cancer incidence and mortality in China, 2012.2012年中国国家癌症发病率与死亡率
Chin J Cancer Res. 2016 Feb;28(1):1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08.
6
Cancer incidence and mortality in Henan province, 2012.2012年河南省癌症发病率与死亡率
Chin J Cancer Res. 2016 Jun;28(3):275-85. doi: 10.21147/j.issn.1000-9604.2016.03.02.
7
Cancer incidence and mortality in Zhejiang Province, Southeast China, 2016: a population-based study.2016 年中国东南浙江省的癌症发病与死亡情况:一项基于人群的研究。
Chin Med J (Engl). 2021 Jul 29;134(16):1959-1966. doi: 10.1097/CM9.0000000000001666.
8
Cancer incidence and mortality in Gansu province, 2012.2012年甘肃省癌症发病率与死亡率
Chin J Cancer Res. 2016 Jun;28(3):301-10. doi: 10.21147/j.issn.1000-9604.2016.03.04.
9
Report of incidence and mortality in china cancer registries, 2008.中国癌症登记地区 2008 年肿瘤登记发病与死亡报告。
Chin J Cancer Res. 2012 Sep;24(3):171-80. doi: 10.1007/s11670-012-0171-2.
10
Annual report on status of cancer in China, 2011.《2011年中国癌症现状年度报告》
Chin J Cancer Res. 2015 Feb;27(1):2-12. doi: 10.3978/j.issn.1000-9604.2015.01.06.

引用本文的文献

1
Effectiveness of early cancer screening and diagnosis in urban China.中国城市早期癌症筛查与诊断的有效性
Sci Rep. 2025 Jul 2;15(1):23160. doi: 10.1038/s41598-025-05020-1.
2
Estimating the Proportion of Overdiagnosis among Prostate, Breast, and Thyroid Cancers in China: Findings from the Global Burden of Disease 2019.估算中国前列腺癌、乳腺癌和甲状腺癌过度诊断的比例:来自 2019 年全球疾病负担研究的发现。
Curr Oncol. 2024 Sep 20;31(9):5643-5651. doi: 10.3390/curroncol31090418.
3
Implementation planning for lung cancer screening in China.中国肺癌筛查的实施规划。
Precis Clin Med. 2019 Mar;2(1):13-44. doi: 10.1093/pcmedi/pbz002. Epub 2019 Mar 14.
4
Pancreatic cancer incidence and mortality patterns in 2006-2015 and prediction of the epidemiological trend to 2025 in China.2006 - 2015年中国胰腺癌的发病率和死亡率模式以及至2025年的流行病学趋势预测
World J Clin Cases. 2022 May 16;10(14):4404-4413. doi: 10.12998/wjcc.v10.i14.4404.
5
Metformin Suppresses the Proliferation and Promotes the Apoptosis of Colon Cancer Cells Through Inhibiting the Expression of Long Noncoding RNA-UCA1.二甲双胍通过抑制长链非编码RNA-UCA1的表达抑制结肠癌细胞增殖并促进其凋亡。
Onco Targets Ther. 2020 May 14;13:4169-4181. doi: 10.2147/OTT.S245091. eCollection 2020.
6
Decreased CCDC19 is correlated with unfavorable outcome in lung squamous cell carcinoma.CCDC19表达降低与肺鳞状细胞癌的不良预后相关。
Int J Clin Exp Pathol. 2018 Feb 1;11(2):802-807. eCollection 2018.
7
Expression of gene in ovarian cancer and its impact on the biologic function of ovarian cancer cells.基因在卵巢癌中的表达及其对卵巢癌细胞生物学功能的影响。
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2572-2584. eCollection 2019.
8
A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer.一个稳健的胃癌病理诊断正确的转录特征的定性分析。
J Transl Med. 2019 Feb 28;17(1):63. doi: 10.1186/s12967-019-1816-4.
9
Downregulation of high mobility group protein box-1 resensitizes ovarian cancer cells to carboplatin.高迁移率族蛋白盒1的下调使卵巢癌细胞对卡铂重新敏感。
Oncol Lett. 2018 Oct;16(4):4586-4592. doi: 10.3892/ol.2018.9232. Epub 2018 Jul 30.
10
Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.白细胞介素-22 (IL-22) 通过 c-Jun N-末端激酶信号通路调节紫杉醇耐药的非小细胞肺癌细胞的凋亡。
Med Sci Monit. 2018 May 3;24:2750-2757. doi: 10.12659/MSM.907336.